64 related articles for article (PubMed ID: 25735368)
1. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.
Zekri AR; Youssef AS; Bakr YM; Gabr RM; El-Rouby MN; Hammad I; Ahmed EA; Marzouk HA; Nabil MM; Hamed HA; Aly YH; Zachariah KS; Esmat G
Asian Pac J Cancer Prev; 2015; 16(3):1281-7. PubMed ID: 25735368
[TBL] [Abstract][Full Text] [Related]
2. Clinical Utility of Cytokeratins for Accurate Diagnosis of Hepatocellular Carcinoma Among Hepatitis C Virus High-Risk Patients.
Al Haddad M; El-Mezayen HA; El-Kassas M; Metwally F; El-Sharkawy A
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1325-1332. PubMed ID: 38679993
[TBL] [Abstract][Full Text] [Related]
3. Serum ApoB/ApoA1 ratio in patients with CHB and the occurrence of HBV related cirrhosis and HBV related hepatocellular carcinoma.
Cai X; Peng S; Xiao X; Huang Z; Zhang P
Sci Rep; 2024 May; 14(1):10996. PubMed ID: 38744926
[TBL] [Abstract][Full Text] [Related]
4. OPN is a promising serological biomarker for hepatocellular carcinoma diagnosis.
Zhu M; Zheng J; Wu F; Kang B; Liang J; Heskia F; Zhang X; Shan Y
J Med Virol; 2020 Dec; 92(12):3596-3603. PubMed ID: 32043608
[TBL] [Abstract][Full Text] [Related]
5. Mass-selected site-specific core-fucosylation of ceruloplasmin in alcohol-related hepatocellular carcinoma.
Yin H; Lin Z; Nie S; Wu J; Tan Z; Zhu J; Dai J; Feng Z; Marrero J; Lubman DM
J Proteome Res; 2014 Jun; 13(6):2887-96. PubMed ID: 24799124
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Circular RNA SMARCA5 as a Novel Biomarker for Hepatocellular Carcinoma.
Bedair HM; El-Banna EA; Ahmed EA; Elhelbawy MG; Abdelfattah A; Khalaf FA; Abdel-Samiee M; El Sharnoby A
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1411-1417. PubMed ID: 38680002
[TBL] [Abstract][Full Text] [Related]
7. Serum microRNA-16 as a potential biomarker for HCV-induced hepato-cellular carcinoma in Egyptian patients.
El Hawary AT; Nabil F; El Hendawy R; Mahrous HKA; AbdelHamid GA; Amer M
Egypt J Immunol; 2024 Apr; 31(2):102-111. PubMed ID: 38615267
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma.
Golam RM; Khalil MAF; Shaker OG; Ahmed TI; Elguaad MKA; Hassan EA; El-Ansary MRM; Ismail A; Kandil YI; Mohammed OA; Doghish AS
PLoS One; 2024; 19(5):e0303314. PubMed ID: 38739668
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Performance of Epithelial Cell Adhesion Molecule for Early Detection of Hepatocellular Carcinoma Among HCV High-Risk Patients.
Nasser R; Al Haddad M; El-Kassas MM; Metwally FM; El-Mezayen HA; El-Sharkawy A
Asian Pac J Cancer Prev; 2024 Mar; 25(3):1045-1052. PubMed ID: 38546087
[TBL] [Abstract][Full Text] [Related]
10. Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.
Dengler M; Staufer K; Huber H; Stauber R; Bantel H; Weiss KH; Starlinger P; Pock H; Klöters-Plachky P; Gotthardt DN; Rauch P; Lackner C; Stift J; Brostjan C; Gruenberger T; Kumada T; Toyoda H; Tada T; Weiss TS; Trauner M; Mikulits W
Oncotarget; 2017 Jul; 8(28):46234-46248. PubMed ID: 28526812
[TBL] [Abstract][Full Text] [Related]
11. Impact of deranged B cell subsets distribution in the development of HCV-related cirrhosis and HCC in type two diabetes mellitus.
Abdelwahab FA; Hassanein KM; Hetta HF; Abdelmalek MO; Zahran AM; El-Badawy O
Sci Rep; 2020 Nov; 10(1):20383. PubMed ID: 33230233
[TBL] [Abstract][Full Text] [Related]
12. Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort study.
Guo DZ; Huang A; Wang YC; Zhou S; Wang H; Xing XL; Zhang SY; Cheng JW; Xie KH; Yang QC; Ma CC; Li Q; Chen Y; Su ZX; Fan J; Liu R; Liu XL; Zhou J; Yang XR
Clin Transl Med; 2024 May; 14(5):e1652. PubMed ID: 38741204
[TBL] [Abstract][Full Text] [Related]
13. The Putative Role of Natural Killer Cells in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma.
Hassouna MM; Radwan EM; Abdelsameea E; Estaphan S; Abd Elrhman HE; Abdel-Samiee M; Naguib M
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2559-2567. PubMed ID: 34452571
[TBL] [Abstract][Full Text] [Related]
14. Plasma Heat Shock Protein 90alpha as a Biomarker for the Diagnosis of Liver Cancer: An Official, Large-scale, and Multicenter Clinical Trial.
Fu Y; Xu X; Huang D; Cui D; Liu L; Liu J; He Z; Liu J; Zheng S; Luo Y
EBioMedicine; 2017 Oct; 24():56-63. PubMed ID: 28939487
[TBL] [Abstract][Full Text] [Related]
15. Serum interleukin-10 and alpha-fetoprotein: A combined diagnostic approach for hepatocellular carcinoma in Egyptians with HCV.
Sharafeldin MA; Suef RA; Mousa AA; Ziadah DH; Farag MMS
Pathol Res Pract; 2024 Apr; 258():155327. PubMed ID: 38692084
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the Clinical Value of Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma.
Chen X; Mohammed AF; Li C
Clin Appl Thromb Hemost; 2024; 30():10760296231221535. PubMed ID: 38591958
[TBL] [Abstract][Full Text] [Related]
17. A Circulating MicroRNA Signature Capable of Assessing the Risk of Hepatocellular Carcinoma in Cirrhotic Patients.
Huang YH; Liang KH; Chien RN; Hu TH; Lin KH; Hsu CW; Lin CL; Pan TL; Ke PY; Yeh CT
Sci Rep; 2017 Mar; 7(1):523. PubMed ID: 28364124
[TBL] [Abstract][Full Text] [Related]
18. A new biomarker panel for differential diagnosis of cholangiocarcinoma: Results from an exploratory analysis.
Köhler B; Bes M; Chan HL; Esteban JI; Piratvisuth T; Sukeepaisarnjaroen W; Tanwandee T; Thongsawat S; Mang A; Morgenstern D; Swiatek-de Lange M; Dayyani F
Int J Biol Markers; 2024 Jun; 39(2):107-117. PubMed ID: 38549363
[TBL] [Abstract][Full Text] [Related]
19. HCC-Check: A Novel Diagnostic Tool for Early Detection of Hepatocellular Carcinoma Based on Cytokeratin-1 and Epithelial Membrane Antigen: A Cross-Sectional Study.
Attallah KA; Albannan MS; Farid K; Rizk SM; Fathy N
Technol Cancer Res Treat; 2024; 23():15330338241234790. PubMed ID: 38436112
[No Abstract] [Full Text] [Related]
20. Serum human endothelial cell-specific molecule-1 (endocan) and vascular endothelial growth factor in cirrhotic HCV patients with hepatocellular carcinoma as predictors of mortality.
Youssef AA; Issa HA; Omar MZ; Behiry EG; Elfallah AA; Hasaneen A; Darwish M; Ibrahim DB
Clin Exp Gastroenterol; 2018; 11():431-438. PubMed ID: 30538523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
